Met Life Investment Management, LLC Accolade, Inc. Transaction History
Met Life Investment Management, LLC
- $16.6 Billion
- Q2 2024
A detailed history of Met Life Investment Management, LLC transactions in Accolade, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 43,322 shares of ACCD stock, worth $167,222. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,322
Previous 34,620
25.14%
Holding current value
$167,222
Previous $362,000
57.18%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding ACCD
# of Institutions
168Shares Held
66.3MCall Options Held
61KPut Options Held
566K-
Black Rock Inc. New York, NY6.16MShares$23.8 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.64MShares$21.8 Million0.18% of portfolio
-
Brown Advisory Inc5.45MShares$21 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.12MShares$15.9 Million0.0% of portfolio
-
Ah Equity Partners Iv (Parallel), L.L.C. Menlo Park, CA3.78MShares$14.6 Million88.81% of portfolio
About Accolade, Inc.
- Ticker ACCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 71,938,896
- Market Cap $278M
- Description
- Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...